ATLANTA Lacosamide Conversion to Monotherapy for the Treatment of Partial-Onset Seizures: Results from a Historical-Controlled, Multicenter, Double-Blind, Randomized TrialAbstract 1.227; Poster Session 1; Saturday, December 7 Epilepsy is a ... TheStreet.com, 2 weeks ago
American Epilepsy Society - ClinicSpace, 1 month ago
New Data From s Epilepsy Portfolio To Be Highlighted At The 67th Annual Meeting Of The American Epilepsy Society - BioSpace, 2 weeks ago
2 images for "lacosamide"
UCB files VIMPAT (lacosamide) in the US as monotherapy treatment in adult epilepsy patients with partial-onset seizures - Results from VIMPAT (lacosamide) monotherapy study supporting this filing to be presented at AES 2013 ATLANTA, Nov. 4, 2013 ...Big News Network, 1 month ago UCB files VIMPAT (lacosamide) in the US as monotherapy treatment in adult epilepsy patients with partial-onset seizures Pharmacy Choice, 1 month ago UCB files VIMPAT® (lacosamide) in the US as monotherapy treatment in adult epilepsy patients with partial-onset seizures Reuters, 1 month ago UCB, Inc. Files VIMPAT (Lacosamide) in the U.S. as Monotherapy Treatment in Adult Epilepsy Patients With Partial-Onset Seizures BioSpace, 1 month ago
News Categories Clinical Trials Research News Industry Trends AgencyPharmscope, 1 month ago UCB's sNDA for epilepsy therapy receives FDA acceptance for filing Individual.com, 3 weeks ago
Brussels (Belgium) Comprehensive analyses of pooled data from three randomized, double-blind, placebo-controlled Phase II/III trials showing the efficacy and tolerability of Vimpat® (lacosamide) for patients with partial onset seizures, regardless ...Hospital Pharmacy Europe, 2 months ago
Belgian pharmaceutical group UCB has announced results based on first-line analyses of its phase IIa clinical trial with lacosamide to treat fibromyalgia syndrome. The initial results from this proof of concept study showed activity of lacosamide ...Hospital Pharmacy Europe, 2 months ago
By Kurt R. Karst The number of citizen petitions pending at FDA concerning Hatch-Waxman exclusivity continues to pile up. As we previously reported ( here and here ), FDA has already been asked on three separate occasions in 2013 to recognize ...MedCity News, 6 days ago
The National Institute for Health and Care Excellence recommends offering a choice of amitriptyline, duloxetine, gabapentin or pregabalin as initial treatment for neuropathic pain (except trigeminal neuralgia), in its updated guideline on the ...PJ Online, 1 week ago
GPs should think carefully before changing a particular form of antiepileptic drug (AED) when prescribing them to their patients, according to new guidance from the Medicines and Healthcare products Regulatory Agency (MHRA). The MHRA has issued new ...OnMedicanet, 3 weeks ago Antiepileptic drugs categorised to help prescribers avoid switching risks PJ Online, 3 weeks ago Antiepileptics: changing products MHRA, 3 weeks ago
Time: 09:00 Subject: MHRA issues new guidance to prescribers, pharmacists and patients in relation to anti-epileptic drugs (AEDs). Contact: Press Office 020 3080 7651 or firstname.lastname@example.org Out-of-hours 07770 446 189 The Medicines and ...MHRA, 3 weeks ago
About 1 in 3 U.S. adults isn't getting recommended screening (November 5) Colorectal cancer is the second leading cancer killer among men and women in the U.S., after lung cancer. About 1 in 3 adults is not getting screened for colorectal cancer ...PT Community, 1 month ago
on your WebpageAdd Widget >Get your members hooked!